BDBM327813 US9663475, Compound A23::US9663475, Compound A24

SMILES CCN(CC)C(=O)c1ccc2CN(C3Cc4ccccc4C3)C(N)=Nc2c1

InChI Key InChIKey=IPZWZCNMWSVBLQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 327813   

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327813(US9663475, Compound A24 | US9663475, Compound A23)
Affinity DataIC50: 2.90E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327813(US9663475, Compound A24 | US9663475, Compound A23)
Affinity DataIC50: 4.20E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent